kombinationsbehandling (herunder Atripla) kan give øget blodsukker, øge fedtindholdet i blodet (hyperlipæmi), give ændringer i fedtfordelingen samt resistens over for insulin (se pkt.
Combination antiretroviral therapies (including Atripla) may raise blood sugar levels, increase blood fats (hyperlipaemia), cause changes to body fat, and resistance to insulin (see Section 4, Possible side effects).